JAK2 and acquired polycythemia vera: Although PV has been characterized as having relatively genome-stable conditions compared to other MPNs [81], the JAK2 V617F mutation present in nearly 98% of PV cases may still contribute to DNA damage response alterations [82], potentially linking the observed purine metabolism dysregulation to underlying genomic stress mechanisms.